Global Multimodal Imaging Market

Multimodal Imaging Comprehensive Study by Type (Systems, Software, Reagents), Application (Neuropsychiatry, Cardiology, Oncology, Ophthalmology, Others), Technology (PET-CT Systems, SPECT-CT Systems, PET-MR Systems, Others), End-User (Hospitals, Diagnostic Imaging Centers, Academia, Others) Players and Region - Global Market Outlook to 2026

Multimodal Imaging Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Multimodal Imaging Market Scope
Multimodal imaging is defined as the simultaneous production of signals for more than one imaging technique. They are extensively used in pre-clinical research. Owing to a rapid increase in the geriatric population and technological advancements in the development of imaging systems, this industry has witnessed steady growth. The recent developments in multimodal imaging-based on nanoparticles have also garnered extensive consumer attention. The use of multimodal imaging in addiction research will open a promising avenue for future innovations.

The Multimodal Imaging market study is segmented by Type (Systems, Software and Reagents), by Application (Neuropsychiatry, Cardiology, Oncology, Ophthalmology and Others) and major geographies with country level break-up.

Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Multimodal Imaging market throughout the predicted period.

Bruker Corporation (United States), PerkinElmer, Inc. (United States), Northridge Tri-Modality Imaging, Inc. (United States), GE Healthcare (United States), Carl Zeiss AG (Germany), Spectrum Dynamics Medical (Switzerland), Koninklijke Philips N.V. (Netherlands), United Imaging Healthcare Co., Ltd. (China), Heidelberg Engineering (Germany) and Canon Medical Systems Corporation (Japan) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are MR Solutions Ltd. (United Kingdom), MILabs B.V. (Netherlands), Mediso Medical Imaging Kft (Hungary), Siemens Healthineers (Germany), Neusoft Medical Systems Co., Ltd. (China), Infraredx, Inc. (Japan) and Topcon Corporation (Japan).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Multimodal Imaging market by Type, Application and Region.

On the basis of geography, the market of Multimodal Imaging has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Leaders and their expansionary development strategies
In 2016, Canon Inc. has completed the acquisition of Toshiba Medical Systems Corporation, with the aim to include its diagnostic imaging portfolio in its offering and expand its healthcare business, globally.
In September 2018, Bruker Corporation has introduced a new preclinical PET/CT Si78r system. This system not only answers the latest needs of preclinical imaging scientists but also provides whole-body CT scan in less than seven seconds.


Market Trend
  • Photoacoustic Imaging in both Clinical and Pre-Clinical Applications
  • Recent Introduction of Systems that Combine PET and MRI

Market Drivers
  • Increasing Use in Drug Discovery and In Invasive and Non-Invasive Surgical Interventions
  • Growing Prevalence of Chronic Illness in Geriatric Population across the Unites States
  • Technological Advancements in Diagnostic Imaging Modalities

Opportunities
  • Technological Innovations and Development of New Tracers and Smart Probes
  • Simultaneous Acquisition of Multifunctional Data Such As PET Tracer Uptake, MR Spectroscopy

Restraints
  • High Cost of Multimodal Imaging Systems
  • Lack of Adequate Healthcare Infrastructure

Challenges
  • Each Imaging Modality Offers Its Own Unique Strengths Such As Resolution, Sensitivity, or Throughput
  • Lack of Skilled Professional


Key Target Audience
Multimodal Imaging Technology Providers, System and Software Developers, Laboratories & Research Institutes, Pharmaceutical Companies, End-Use Industries and Others

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase

Report Objectives / Segmentation Covered

By Type
  • Systems
  • Software
  • Reagents
By Application
  • Neuropsychiatry
  • Cardiology
  • Oncology
  • Ophthalmology
  • Others
By Technology
  • PET-CT Systems
  • SPECT-CT Systems
  • PET-MR Systems
  • Others

By End-User
  • Hospitals
  • Diagnostic Imaging Centers
  • Academia
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Use in Drug Discovery and In Invasive and Non-Invasive Surgical Interventions
      • 3.2.2. Growing Prevalence of Chronic Illness in Geriatric Population across the Unites States
      • 3.2.3. Technological Advancements in Diagnostic Imaging Modalities
    • 3.3. Market Challenges
      • 3.3.1. Each Imaging Modality Offers Its Own Unique Strengths Such As Resolution, Sensitivity, or Throughput
      • 3.3.2. Lack of Skilled Professional
    • 3.4. Market Trends
      • 3.4.1. Photoacoustic Imaging in both Clinical and Pre-Clinical Applications
      • 3.4.2. Recent Introduction of Systems that Combine PET and MRI
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Multimodal Imaging, by Type, Application, Technology, End-User and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Multimodal Imaging (Value)
      • 5.2.1. Global Multimodal Imaging by: Type (Value)
        • 5.2.1.1. Systems
        • 5.2.1.2. Software
        • 5.2.1.3. Reagents
      • 5.2.2. Global Multimodal Imaging by: Application (Value)
        • 5.2.2.1. Neuropsychiatry
        • 5.2.2.2. Cardiology
        • 5.2.2.3. Oncology
        • 5.2.2.4. Ophthalmology
        • 5.2.2.5. Others
      • 5.2.3. Global Multimodal Imaging by: Technology (Value)
        • 5.2.3.1. PET-CT Systems
        • 5.2.3.2. SPECT-CT Systems
        • 5.2.3.3. PET-MR Systems
        • 5.2.3.4. Others
      • 5.2.4. Global Multimodal Imaging by: End-User (Value)
        • 5.2.4.1. Hospitals
        • 5.2.4.2. Diagnostic Imaging Centers
        • 5.2.4.3. Academia
        • 5.2.4.4. Others
      • 5.2.5. Global Multimodal Imaging Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Multimodal Imaging: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Bruker Corporation (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. PerkinElmer, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Northridge Tri-Modality Imaging, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. GE Healthcare (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Carl Zeiss AG (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Spectrum Dynamics Medical (Switzerland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Koninklijke Philips N.V. (Netherlands)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. United Imaging Healthcare Co., Ltd. (China)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Heidelberg Engineering (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Canon Medical Systems Corporation (Japan)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Multimodal Imaging Sale, by Type, Application, Technology, End-User and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Multimodal Imaging (Value)
      • 7.2.1. Global Multimodal Imaging by: Type (Value)
        • 7.2.1.1. Systems
        • 7.2.1.2. Software
        • 7.2.1.3. Reagents
      • 7.2.2. Global Multimodal Imaging by: Application (Value)
        • 7.2.2.1. Neuropsychiatry
        • 7.2.2.2. Cardiology
        • 7.2.2.3. Oncology
        • 7.2.2.4. Ophthalmology
        • 7.2.2.5. Others
      • 7.2.3. Global Multimodal Imaging by: Technology (Value)
        • 7.2.3.1. PET-CT Systems
        • 7.2.3.2. SPECT-CT Systems
        • 7.2.3.3. PET-MR Systems
        • 7.2.3.4. Others
      • 7.2.4. Global Multimodal Imaging by: End-User (Value)
        • 7.2.4.1. Hospitals
        • 7.2.4.2. Diagnostic Imaging Centers
        • 7.2.4.3. Academia
        • 7.2.4.4. Others
      • 7.2.5. Global Multimodal Imaging Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Multimodal Imaging: by Type(USD Million)
  • Table 2. Multimodal Imaging Systems , by Region USD Million (2015-2020)
  • Table 3. Multimodal Imaging Software , by Region USD Million (2015-2020)
  • Table 4. Multimodal Imaging Reagents , by Region USD Million (2015-2020)
  • Table 5. Multimodal Imaging: by Application(USD Million)
  • Table 6. Multimodal Imaging Neuropsychiatry , by Region USD Million (2015-2020)
  • Table 7. Multimodal Imaging Cardiology , by Region USD Million (2015-2020)
  • Table 8. Multimodal Imaging Oncology , by Region USD Million (2015-2020)
  • Table 9. Multimodal Imaging Ophthalmology , by Region USD Million (2015-2020)
  • Table 10. Multimodal Imaging Others , by Region USD Million (2015-2020)
  • Table 11. Multimodal Imaging: by Technology(USD Million)
  • Table 12. Multimodal Imaging PET-CT Systems , by Region USD Million (2015-2020)
  • Table 13. Multimodal Imaging SPECT-CT Systems , by Region USD Million (2015-2020)
  • Table 14. Multimodal Imaging PET-MR Systems , by Region USD Million (2015-2020)
  • Table 15. Multimodal Imaging Others , by Region USD Million (2015-2020)
  • Table 16. Multimodal Imaging: by End-User(USD Million)
  • Table 17. Multimodal Imaging Hospitals , by Region USD Million (2015-2020)
  • Table 18. Multimodal Imaging Diagnostic Imaging Centers , by Region USD Million (2015-2020)
  • Table 19. Multimodal Imaging Academia , by Region USD Million (2015-2020)
  • Table 20. Multimodal Imaging Others , by Region USD Million (2015-2020)
  • Table 21. South America Multimodal Imaging, by Country USD Million (2015-2020)
  • Table 22. South America Multimodal Imaging, by Type USD Million (2015-2020)
  • Table 23. South America Multimodal Imaging, by Application USD Million (2015-2020)
  • Table 24. South America Multimodal Imaging, by Technology USD Million (2015-2020)
  • Table 25. South America Multimodal Imaging, by End-User USD Million (2015-2020)
  • Table 26. Brazil Multimodal Imaging, by Type USD Million (2015-2020)
  • Table 27. Brazil Multimodal Imaging, by Application USD Million (2015-2020)
  • Table 28. Brazil Multimodal Imaging, by Technology USD Million (2015-2020)
  • Table 29. Brazil Multimodal Imaging, by End-User USD Million (2015-2020)
  • Table 30. Argentina Multimodal Imaging, by Type USD Million (2015-2020)
  • Table 31. Argentina Multimodal Imaging, by Application USD Million (2015-2020)
  • Table 32. Argentina Multimodal Imaging, by Technology USD Million (2015-2020)
  • Table 33. Argentina Multimodal Imaging, by End-User USD Million (2015-2020)
  • Table 34. Rest of South America Multimodal Imaging, by Type USD Million (2015-2020)
  • Table 35. Rest of South America Multimodal Imaging, by Application USD Million (2015-2020)
  • Table 36. Rest of South America Multimodal Imaging, by Technology USD Million (2015-2020)
  • Table 37. Rest of South America Multimodal Imaging, by End-User USD Million (2015-2020)
  • Table 38. Asia Pacific Multimodal Imaging, by Country USD Million (2015-2020)
  • Table 39. Asia Pacific Multimodal Imaging, by Type USD Million (2015-2020)
  • Table 40. Asia Pacific Multimodal Imaging, by Application USD Million (2015-2020)
  • Table 41. Asia Pacific Multimodal Imaging, by Technology USD Million (2015-2020)
  • Table 42. Asia Pacific Multimodal Imaging, by End-User USD Million (2015-2020)
  • Table 43. China Multimodal Imaging, by Type USD Million (2015-2020)
  • Table 44. China Multimodal Imaging, by Application USD Million (2015-2020)
  • Table 45. China Multimodal Imaging, by Technology USD Million (2015-2020)
  • Table 46. China Multimodal Imaging, by End-User USD Million (2015-2020)
  • Table 47. Japan Multimodal Imaging, by Type USD Million (2015-2020)
  • Table 48. Japan Multimodal Imaging, by Application USD Million (2015-2020)
  • Table 49. Japan Multimodal Imaging, by Technology USD Million (2015-2020)
  • Table 50. Japan Multimodal Imaging, by End-User USD Million (2015-2020)
  • Table 51. India Multimodal Imaging, by Type USD Million (2015-2020)
  • Table 52. India Multimodal Imaging, by Application USD Million (2015-2020)
  • Table 53. India Multimodal Imaging, by Technology USD Million (2015-2020)
  • Table 54. India Multimodal Imaging, by End-User USD Million (2015-2020)
  • Table 55. South Korea Multimodal Imaging, by Type USD Million (2015-2020)
  • Table 56. South Korea Multimodal Imaging, by Application USD Million (2015-2020)
  • Table 57. South Korea Multimodal Imaging, by Technology USD Million (2015-2020)
  • Table 58. South Korea Multimodal Imaging, by End-User USD Million (2015-2020)
  • Table 59. Taiwan Multimodal Imaging, by Type USD Million (2015-2020)
  • Table 60. Taiwan Multimodal Imaging, by Application USD Million (2015-2020)
  • Table 61. Taiwan Multimodal Imaging, by Technology USD Million (2015-2020)
  • Table 62. Taiwan Multimodal Imaging, by End-User USD Million (2015-2020)
  • Table 63. Australia Multimodal Imaging, by Type USD Million (2015-2020)
  • Table 64. Australia Multimodal Imaging, by Application USD Million (2015-2020)
  • Table 65. Australia Multimodal Imaging, by Technology USD Million (2015-2020)
  • Table 66. Australia Multimodal Imaging, by End-User USD Million (2015-2020)
  • Table 67. Rest of Asia-Pacific Multimodal Imaging, by Type USD Million (2015-2020)
  • Table 68. Rest of Asia-Pacific Multimodal Imaging, by Application USD Million (2015-2020)
  • Table 69. Rest of Asia-Pacific Multimodal Imaging, by Technology USD Million (2015-2020)
  • Table 70. Rest of Asia-Pacific Multimodal Imaging, by End-User USD Million (2015-2020)
  • Table 71. Europe Multimodal Imaging, by Country USD Million (2015-2020)
  • Table 72. Europe Multimodal Imaging, by Type USD Million (2015-2020)
  • Table 73. Europe Multimodal Imaging, by Application USD Million (2015-2020)
  • Table 74. Europe Multimodal Imaging, by Technology USD Million (2015-2020)
  • Table 75. Europe Multimodal Imaging, by End-User USD Million (2015-2020)
  • Table 76. Germany Multimodal Imaging, by Type USD Million (2015-2020)
  • Table 77. Germany Multimodal Imaging, by Application USD Million (2015-2020)
  • Table 78. Germany Multimodal Imaging, by Technology USD Million (2015-2020)
  • Table 79. Germany Multimodal Imaging, by End-User USD Million (2015-2020)
  • Table 80. France Multimodal Imaging, by Type USD Million (2015-2020)
  • Table 81. France Multimodal Imaging, by Application USD Million (2015-2020)
  • Table 82. France Multimodal Imaging, by Technology USD Million (2015-2020)
  • Table 83. France Multimodal Imaging, by End-User USD Million (2015-2020)
  • Table 84. Italy Multimodal Imaging, by Type USD Million (2015-2020)
  • Table 85. Italy Multimodal Imaging, by Application USD Million (2015-2020)
  • Table 86. Italy Multimodal Imaging, by Technology USD Million (2015-2020)
  • Table 87. Italy Multimodal Imaging, by End-User USD Million (2015-2020)
  • Table 88. United Kingdom Multimodal Imaging, by Type USD Million (2015-2020)
  • Table 89. United Kingdom Multimodal Imaging, by Application USD Million (2015-2020)
  • Table 90. United Kingdom Multimodal Imaging, by Technology USD Million (2015-2020)
  • Table 91. United Kingdom Multimodal Imaging, by End-User USD Million (2015-2020)
  • Table 92. Netherlands Multimodal Imaging, by Type USD Million (2015-2020)
  • Table 93. Netherlands Multimodal Imaging, by Application USD Million (2015-2020)
  • Table 94. Netherlands Multimodal Imaging, by Technology USD Million (2015-2020)
  • Table 95. Netherlands Multimodal Imaging, by End-User USD Million (2015-2020)
  • Table 96. Rest of Europe Multimodal Imaging, by Type USD Million (2015-2020)
  • Table 97. Rest of Europe Multimodal Imaging, by Application USD Million (2015-2020)
  • Table 98. Rest of Europe Multimodal Imaging, by Technology USD Million (2015-2020)
  • Table 99. Rest of Europe Multimodal Imaging, by End-User USD Million (2015-2020)
  • Table 100. MEA Multimodal Imaging, by Country USD Million (2015-2020)
  • Table 101. MEA Multimodal Imaging, by Type USD Million (2015-2020)
  • Table 102. MEA Multimodal Imaging, by Application USD Million (2015-2020)
  • Table 103. MEA Multimodal Imaging, by Technology USD Million (2015-2020)
  • Table 104. MEA Multimodal Imaging, by End-User USD Million (2015-2020)
  • Table 105. Middle East Multimodal Imaging, by Type USD Million (2015-2020)
  • Table 106. Middle East Multimodal Imaging, by Application USD Million (2015-2020)
  • Table 107. Middle East Multimodal Imaging, by Technology USD Million (2015-2020)
  • Table 108. Middle East Multimodal Imaging, by End-User USD Million (2015-2020)
  • Table 109. Africa Multimodal Imaging, by Type USD Million (2015-2020)
  • Table 110. Africa Multimodal Imaging, by Application USD Million (2015-2020)
  • Table 111. Africa Multimodal Imaging, by Technology USD Million (2015-2020)
  • Table 112. Africa Multimodal Imaging, by End-User USD Million (2015-2020)
  • Table 113. North America Multimodal Imaging, by Country USD Million (2015-2020)
  • Table 114. North America Multimodal Imaging, by Type USD Million (2015-2020)
  • Table 115. North America Multimodal Imaging, by Application USD Million (2015-2020)
  • Table 116. North America Multimodal Imaging, by Technology USD Million (2015-2020)
  • Table 117. North America Multimodal Imaging, by End-User USD Million (2015-2020)
  • Table 118. United States Multimodal Imaging, by Type USD Million (2015-2020)
  • Table 119. United States Multimodal Imaging, by Application USD Million (2015-2020)
  • Table 120. United States Multimodal Imaging, by Technology USD Million (2015-2020)
  • Table 121. United States Multimodal Imaging, by End-User USD Million (2015-2020)
  • Table 122. Canada Multimodal Imaging, by Type USD Million (2015-2020)
  • Table 123. Canada Multimodal Imaging, by Application USD Million (2015-2020)
  • Table 124. Canada Multimodal Imaging, by Technology USD Million (2015-2020)
  • Table 125. Canada Multimodal Imaging, by End-User USD Million (2015-2020)
  • Table 126. Mexico Multimodal Imaging, by Type USD Million (2015-2020)
  • Table 127. Mexico Multimodal Imaging, by Application USD Million (2015-2020)
  • Table 128. Mexico Multimodal Imaging, by Technology USD Million (2015-2020)
  • Table 129. Mexico Multimodal Imaging, by End-User USD Million (2015-2020)
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Multimodal Imaging: by Type(USD Million)
  • Table 141. Multimodal Imaging Systems , by Region USD Million (2021-2026)
  • Table 142. Multimodal Imaging Software , by Region USD Million (2021-2026)
  • Table 143. Multimodal Imaging Reagents , by Region USD Million (2021-2026)
  • Table 144. Multimodal Imaging: by Application(USD Million)
  • Table 145. Multimodal Imaging Neuropsychiatry , by Region USD Million (2021-2026)
  • Table 146. Multimodal Imaging Cardiology , by Region USD Million (2021-2026)
  • Table 147. Multimodal Imaging Oncology , by Region USD Million (2021-2026)
  • Table 148. Multimodal Imaging Ophthalmology , by Region USD Million (2021-2026)
  • Table 149. Multimodal Imaging Others , by Region USD Million (2021-2026)
  • Table 150. Multimodal Imaging: by Technology(USD Million)
  • Table 151. Multimodal Imaging PET-CT Systems , by Region USD Million (2021-2026)
  • Table 152. Multimodal Imaging SPECT-CT Systems , by Region USD Million (2021-2026)
  • Table 153. Multimodal Imaging PET-MR Systems , by Region USD Million (2021-2026)
  • Table 154. Multimodal Imaging Others , by Region USD Million (2021-2026)
  • Table 155. Multimodal Imaging: by End-User(USD Million)
  • Table 156. Multimodal Imaging Hospitals , by Region USD Million (2021-2026)
  • Table 157. Multimodal Imaging Diagnostic Imaging Centers , by Region USD Million (2021-2026)
  • Table 158. Multimodal Imaging Academia , by Region USD Million (2021-2026)
  • Table 159. Multimodal Imaging Others , by Region USD Million (2021-2026)
  • Table 160. South America Multimodal Imaging, by Country USD Million (2021-2026)
  • Table 161. South America Multimodal Imaging, by Type USD Million (2021-2026)
  • Table 162. South America Multimodal Imaging, by Application USD Million (2021-2026)
  • Table 163. South America Multimodal Imaging, by Technology USD Million (2021-2026)
  • Table 164. South America Multimodal Imaging, by End-User USD Million (2021-2026)
  • Table 165. Brazil Multimodal Imaging, by Type USD Million (2021-2026)
  • Table 166. Brazil Multimodal Imaging, by Application USD Million (2021-2026)
  • Table 167. Brazil Multimodal Imaging, by Technology USD Million (2021-2026)
  • Table 168. Brazil Multimodal Imaging, by End-User USD Million (2021-2026)
  • Table 169. Argentina Multimodal Imaging, by Type USD Million (2021-2026)
  • Table 170. Argentina Multimodal Imaging, by Application USD Million (2021-2026)
  • Table 171. Argentina Multimodal Imaging, by Technology USD Million (2021-2026)
  • Table 172. Argentina Multimodal Imaging, by End-User USD Million (2021-2026)
  • Table 173. Rest of South America Multimodal Imaging, by Type USD Million (2021-2026)
  • Table 174. Rest of South America Multimodal Imaging, by Application USD Million (2021-2026)
  • Table 175. Rest of South America Multimodal Imaging, by Technology USD Million (2021-2026)
  • Table 176. Rest of South America Multimodal Imaging, by End-User USD Million (2021-2026)
  • Table 177. Asia Pacific Multimodal Imaging, by Country USD Million (2021-2026)
  • Table 178. Asia Pacific Multimodal Imaging, by Type USD Million (2021-2026)
  • Table 179. Asia Pacific Multimodal Imaging, by Application USD Million (2021-2026)
  • Table 180. Asia Pacific Multimodal Imaging, by Technology USD Million (2021-2026)
  • Table 181. Asia Pacific Multimodal Imaging, by End-User USD Million (2021-2026)
  • Table 182. China Multimodal Imaging, by Type USD Million (2021-2026)
  • Table 183. China Multimodal Imaging, by Application USD Million (2021-2026)
  • Table 184. China Multimodal Imaging, by Technology USD Million (2021-2026)
  • Table 185. China Multimodal Imaging, by End-User USD Million (2021-2026)
  • Table 186. Japan Multimodal Imaging, by Type USD Million (2021-2026)
  • Table 187. Japan Multimodal Imaging, by Application USD Million (2021-2026)
  • Table 188. Japan Multimodal Imaging, by Technology USD Million (2021-2026)
  • Table 189. Japan Multimodal Imaging, by End-User USD Million (2021-2026)
  • Table 190. India Multimodal Imaging, by Type USD Million (2021-2026)
  • Table 191. India Multimodal Imaging, by Application USD Million (2021-2026)
  • Table 192. India Multimodal Imaging, by Technology USD Million (2021-2026)
  • Table 193. India Multimodal Imaging, by End-User USD Million (2021-2026)
  • Table 194. South Korea Multimodal Imaging, by Type USD Million (2021-2026)
  • Table 195. South Korea Multimodal Imaging, by Application USD Million (2021-2026)
  • Table 196. South Korea Multimodal Imaging, by Technology USD Million (2021-2026)
  • Table 197. South Korea Multimodal Imaging, by End-User USD Million (2021-2026)
  • Table 198. Taiwan Multimodal Imaging, by Type USD Million (2021-2026)
  • Table 199. Taiwan Multimodal Imaging, by Application USD Million (2021-2026)
  • Table 200. Taiwan Multimodal Imaging, by Technology USD Million (2021-2026)
  • Table 201. Taiwan Multimodal Imaging, by End-User USD Million (2021-2026)
  • Table 202. Australia Multimodal Imaging, by Type USD Million (2021-2026)
  • Table 203. Australia Multimodal Imaging, by Application USD Million (2021-2026)
  • Table 204. Australia Multimodal Imaging, by Technology USD Million (2021-2026)
  • Table 205. Australia Multimodal Imaging, by End-User USD Million (2021-2026)
  • Table 206. Rest of Asia-Pacific Multimodal Imaging, by Type USD Million (2021-2026)
  • Table 207. Rest of Asia-Pacific Multimodal Imaging, by Application USD Million (2021-2026)
  • Table 208. Rest of Asia-Pacific Multimodal Imaging, by Technology USD Million (2021-2026)
  • Table 209. Rest of Asia-Pacific Multimodal Imaging, by End-User USD Million (2021-2026)
  • Table 210. Europe Multimodal Imaging, by Country USD Million (2021-2026)
  • Table 211. Europe Multimodal Imaging, by Type USD Million (2021-2026)
  • Table 212. Europe Multimodal Imaging, by Application USD Million (2021-2026)
  • Table 213. Europe Multimodal Imaging, by Technology USD Million (2021-2026)
  • Table 214. Europe Multimodal Imaging, by End-User USD Million (2021-2026)
  • Table 215. Germany Multimodal Imaging, by Type USD Million (2021-2026)
  • Table 216. Germany Multimodal Imaging, by Application USD Million (2021-2026)
  • Table 217. Germany Multimodal Imaging, by Technology USD Million (2021-2026)
  • Table 218. Germany Multimodal Imaging, by End-User USD Million (2021-2026)
  • Table 219. France Multimodal Imaging, by Type USD Million (2021-2026)
  • Table 220. France Multimodal Imaging, by Application USD Million (2021-2026)
  • Table 221. France Multimodal Imaging, by Technology USD Million (2021-2026)
  • Table 222. France Multimodal Imaging, by End-User USD Million (2021-2026)
  • Table 223. Italy Multimodal Imaging, by Type USD Million (2021-2026)
  • Table 224. Italy Multimodal Imaging, by Application USD Million (2021-2026)
  • Table 225. Italy Multimodal Imaging, by Technology USD Million (2021-2026)
  • Table 226. Italy Multimodal Imaging, by End-User USD Million (2021-2026)
  • Table 227. United Kingdom Multimodal Imaging, by Type USD Million (2021-2026)
  • Table 228. United Kingdom Multimodal Imaging, by Application USD Million (2021-2026)
  • Table 229. United Kingdom Multimodal Imaging, by Technology USD Million (2021-2026)
  • Table 230. United Kingdom Multimodal Imaging, by End-User USD Million (2021-2026)
  • Table 231. Netherlands Multimodal Imaging, by Type USD Million (2021-2026)
  • Table 232. Netherlands Multimodal Imaging, by Application USD Million (2021-2026)
  • Table 233. Netherlands Multimodal Imaging, by Technology USD Million (2021-2026)
  • Table 234. Netherlands Multimodal Imaging, by End-User USD Million (2021-2026)
  • Table 235. Rest of Europe Multimodal Imaging, by Type USD Million (2021-2026)
  • Table 236. Rest of Europe Multimodal Imaging, by Application USD Million (2021-2026)
  • Table 237. Rest of Europe Multimodal Imaging, by Technology USD Million (2021-2026)
  • Table 238. Rest of Europe Multimodal Imaging, by End-User USD Million (2021-2026)
  • Table 239. MEA Multimodal Imaging, by Country USD Million (2021-2026)
  • Table 240. MEA Multimodal Imaging, by Type USD Million (2021-2026)
  • Table 241. MEA Multimodal Imaging, by Application USD Million (2021-2026)
  • Table 242. MEA Multimodal Imaging, by Technology USD Million (2021-2026)
  • Table 243. MEA Multimodal Imaging, by End-User USD Million (2021-2026)
  • Table 244. Middle East Multimodal Imaging, by Type USD Million (2021-2026)
  • Table 245. Middle East Multimodal Imaging, by Application USD Million (2021-2026)
  • Table 246. Middle East Multimodal Imaging, by Technology USD Million (2021-2026)
  • Table 247. Middle East Multimodal Imaging, by End-User USD Million (2021-2026)
  • Table 248. Africa Multimodal Imaging, by Type USD Million (2021-2026)
  • Table 249. Africa Multimodal Imaging, by Application USD Million (2021-2026)
  • Table 250. Africa Multimodal Imaging, by Technology USD Million (2021-2026)
  • Table 251. Africa Multimodal Imaging, by End-User USD Million (2021-2026)
  • Table 252. North America Multimodal Imaging, by Country USD Million (2021-2026)
  • Table 253. North America Multimodal Imaging, by Type USD Million (2021-2026)
  • Table 254. North America Multimodal Imaging, by Application USD Million (2021-2026)
  • Table 255. North America Multimodal Imaging, by Technology USD Million (2021-2026)
  • Table 256. North America Multimodal Imaging, by End-User USD Million (2021-2026)
  • Table 257. United States Multimodal Imaging, by Type USD Million (2021-2026)
  • Table 258. United States Multimodal Imaging, by Application USD Million (2021-2026)
  • Table 259. United States Multimodal Imaging, by Technology USD Million (2021-2026)
  • Table 260. United States Multimodal Imaging, by End-User USD Million (2021-2026)
  • Table 261. Canada Multimodal Imaging, by Type USD Million (2021-2026)
  • Table 262. Canada Multimodal Imaging, by Application USD Million (2021-2026)
  • Table 263. Canada Multimodal Imaging, by Technology USD Million (2021-2026)
  • Table 264. Canada Multimodal Imaging, by End-User USD Million (2021-2026)
  • Table 265. Mexico Multimodal Imaging, by Type USD Million (2021-2026)
  • Table 266. Mexico Multimodal Imaging, by Application USD Million (2021-2026)
  • Table 267. Mexico Multimodal Imaging, by Technology USD Million (2021-2026)
  • Table 268. Mexico Multimodal Imaging, by End-User USD Million (2021-2026)
  • Table 269. Research Programs/Design for This Report
  • Table 270. Key Data Information from Secondary Sources
  • Table 271. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Multimodal Imaging: by Type USD Million (2015-2020)
  • Figure 5. Global Multimodal Imaging: by Application USD Million (2015-2020)
  • Figure 6. Global Multimodal Imaging: by Technology USD Million (2015-2020)
  • Figure 7. Global Multimodal Imaging: by End-User USD Million (2015-2020)
  • Figure 8. South America Multimodal Imaging Share (%), by Country
  • Figure 9. Asia Pacific Multimodal Imaging Share (%), by Country
  • Figure 10. Europe Multimodal Imaging Share (%), by Country
  • Figure 11. MEA Multimodal Imaging Share (%), by Country
  • Figure 12. North America Multimodal Imaging Share (%), by Country
  • Figure 13. Global Multimodal Imaging share by Players 2020 (%)
  • Figure 14. Global Multimodal Imaging share by Players (Top 3) 2020(%)
  • Figure 15. Global Multimodal Imaging share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Bruker Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 18. Bruker Corporation (United States) Revenue: by Geography 2020
  • Figure 19. PerkinElmer, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 20. PerkinElmer, Inc. (United States) Revenue: by Geography 2020
  • Figure 21. Northridge Tri-Modality Imaging, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 22. Northridge Tri-Modality Imaging, Inc. (United States) Revenue: by Geography 2020
  • Figure 23. GE Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 24. GE Healthcare (United States) Revenue: by Geography 2020
  • Figure 25. Carl Zeiss AG (Germany) Revenue, Net Income and Gross profit
  • Figure 26. Carl Zeiss AG (Germany) Revenue: by Geography 2020
  • Figure 27. Spectrum Dynamics Medical (Switzerland) Revenue, Net Income and Gross profit
  • Figure 28. Spectrum Dynamics Medical (Switzerland) Revenue: by Geography 2020
  • Figure 29. Koninklijke Philips N.V. (Netherlands) Revenue, Net Income and Gross profit
  • Figure 30. Koninklijke Philips N.V. (Netherlands) Revenue: by Geography 2020
  • Figure 31. United Imaging Healthcare Co., Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 32. United Imaging Healthcare Co., Ltd. (China) Revenue: by Geography 2020
  • Figure 33. Heidelberg Engineering (Germany) Revenue, Net Income and Gross profit
  • Figure 34. Heidelberg Engineering (Germany) Revenue: by Geography 2020
  • Figure 35. Canon Medical Systems Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 36. Canon Medical Systems Corporation (Japan) Revenue: by Geography 2020
  • Figure 37. Global Multimodal Imaging: by Type USD Million (2021-2026)
  • Figure 38. Global Multimodal Imaging: by Application USD Million (2021-2026)
  • Figure 39. Global Multimodal Imaging: by Technology USD Million (2021-2026)
  • Figure 40. Global Multimodal Imaging: by End-User USD Million (2021-2026)
  • Figure 41. South America Multimodal Imaging Share (%), by Country
  • Figure 42. Asia Pacific Multimodal Imaging Share (%), by Country
  • Figure 43. Europe Multimodal Imaging Share (%), by Country
  • Figure 44. MEA Multimodal Imaging Share (%), by Country
  • Figure 45. North America Multimodal Imaging Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Bruker Corporation (United States)
  • PerkinElmer, Inc. (United States)
  • Northridge Tri-Modality Imaging, Inc. (United States)
  • GE Healthcare (United States)
  • Carl Zeiss AG (Germany)
  • Spectrum Dynamics Medical (Switzerland)
  • Koninklijke Philips N.V. (Netherlands)
  • United Imaging Healthcare Co., Ltd. (China)
  • Heidelberg Engineering (Germany)
  • Canon Medical Systems Corporation (Japan)
Additional players considered in the study are as follows:
MR Solutions Ltd. (United Kingdom) , MILabs B.V. (Netherlands) , Mediso Medical Imaging Kft (Hungary) , Siemens Healthineers (Germany) , Neusoft Medical Systems Co., Ltd. (China) , Infraredx, Inc. (Japan) , Topcon Corporation (Japan)
Select User Access Type

Key Highlights of Report


Jun 2021 249 Pages 76 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Multimodal Imaging Market Quantitative research analysis
Global Multimodal Imaging Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Global Multimodal Imaging Market Report?

Have a Query? Click Here

Other Related Reports

Cinacalcet Comprehensive Study by Type (30 mg Tablets, 60 mg Tablets), Application (Hospitals, Medical Research Center, Pharmaceutical Factory, Others), Distribution Channel (Hospitals, Retail Pharma...
$ 3500
Olmesartan Medoxomil  Comprehensive Study by Type (20mg, 40mg), Application (Hypertension, Heart Attacks, Kidney Problems), Drugs (Generic Drugs, Brand Name Drugs), Distribution Channel (Hospitals Ph...
$ 3350
Solifenacin Succinate Drug Comprehensive Study by Type (Idiopathic Bladder Overactivity, Neurogenic Bladder Overactivity), Form (Tablet, Suspension), End User (Hospitals, Clinics), Dosage Availabilit...
$ 3500
Zolmitriptan Comprehensive Study by Type (Nasal Spray, Orally Disintegrating Tablets, Tablets, Others), Patient Age (Children (below 12 years), Adult), Dosage (2.5 mg, 5 mg), Distribution (Hospital ...
$ 3350
Antiprotozoal drugs Comprehensive Study by Type (Chloroquine, Pyrimethamine, Mefloquine, Hydroxychloroquine, Metronidazole, Atovaquone, Others), Application (Healthcare and Hospital, Others), Form (L...
$ 3350
Pediatrics Respiratory Drugs Comprehensive Study by Disease Type (Asthma, Cystic Fibrosis, Bronchiolitis, Pneumonia, Tuberculosis, Others), Distribution Channel (Hospitals & Clinics, Retail Pharmacie...
$ 3750